IP and Antitrust: An Analysis of Antitrust Principles Applied to Intellectual Property Law, Third Edition

Maximize intellectual property rights and minimize antitrust risks with the Third Edition of IP and Antitrust: An Analysis of Antitrust Principles Applied to Intellectual Property Law.  While intellectual property licensing agreements are generally pro-competitive, antitrust issues can arise.  Licensing arrangements raise concerns under the antitrust laws if they are likely to adversely affect the prices, quantities, qualities or varieties of goods and services available.  Therefore, companies MUST factor these antitrust considerations into the drafting and review of these licensing agreements.

The Third Edition of IP and Antitrust: An Analysis of Antitrust Principles Applied to Intellectual Property Law is reorganized and rewritten to address the following important topics:

• Exclusion payment settlements in the pharmaceutical industry
• Post-expiration royalties and payments
• Monopolization and Refusals to License
• Tying, Exclusive Dealing and Related Licensing Practices
• REMS, product hopping and manipulation of the regulatory process
• Package Licensing, Blanket Licenses and Block-Booking
• Anticompetitive Royalty Provisions
• Resale Price Maintenance

Confidently draft and review intellectual property licensing agreements with IP and Antitrust: An Analysis of Antitrust Principles Applied to Intellectual Property Law. 

Note: Online subscriptions are for three-month periods.

Volume I

Part A: Competition Policy and the System of Intellectual Property Rights

• Introduction
• The United States Intellectual Property  System: Key Aspects for the Antitrust  Interface
• Misuse
• Intellectual Property and Market Power
• Jurisdictional and Procedural Issues Governing Antitrust/Intellectual Property Claims
• Remedies for Anticompetitive Abuses of Intellectual Property Rights
• Anticompetitive Settlement of Intellectual Property Disputes

Part B: Monopolistic Practices Involving Intellectual Property Rights

• Monopolization
• Improper Enforcement of Intellectual  Property Claims
• Innovation and Product Changes
• Unilateral Refusals to License
• Patent and Other Intellectual Property Acquisitions; Nonuse
• Manipulation of the Regulatory Process
• Patent Settlements and Other Collective Action in the Pharmaceutical Industry

Part C: Vertical Integration and Related Licensing Practices by Intellectual Property Holders

• Vertical Practices Involving Intellectual Property Rights: Preliminary Issues
• Tying, Exclusive Dealing, and Related Licensing Practices
• Package Licensing, Blanket Licenses, and Block-Booking
• anticompetitive Royalty Provisions
• Resale Price Maintenance, the First Sale Doctrine, and Vertically Imposed Nonprice Restraints
• Grantback Provisions

VOLUME II

Part D: Horizontal Restraints Involving Intellectual Property Licensing

• Justifications and Basic Competitive Concerns
• Price Restricted Licenses and the General Electric Rule
• Output Restricted Licenses
• Horizontal Market Division and Other Nonprice Restrictions
• Cross-Licensing and Patent Pools
• Intellectual Property and Standard-Setting Organizations
• Research and Production Joint Ventures; National Cooperative Research And  Production Act

Part E: Competition and Intellectual Property Licensing in Global Markets

• International Standards for The Intellectual Property/Antitrust Interface
• Application of United States Antitrust Law to International Licensing Arrangements
• The Intellectual Property/Competition Law Interface: Europe
• The Intellectual Property/Competition Law Interface: Canada
• The Intellectual Property/Competition Law Interface: China
• The Intellectual Property/Competition Law Interface: Japan
• The Intellectual Property/Competition  Law Interface: Korea

APPENDICES

• A: Selected Federal Statutes
• B: Antitrust Guidelines for the Licensing  of Intellectual Property
• C: Antitrust Enforcement Guidelines for International Operations
• D: International Materials
• E: European Materials
• F: Canadian Materials